Literature DB >> 21094257

Structural basis of triclosan resistance.

N Jiten Singh1, Dongkyu Shin, Han Myoung Lee, Hyun Tae Kim, Ho-Jin Chang, Joong Myung Cho, Kwang S Kim, Seonggu Ro.   

Abstract

Triclosan (5-chloro-2-(2,4-dichloro-phenoxy)-phenol, TCL) is a well known inhibitor against enoyl-acyl carrier protein reductase (ENR), an enzyme critical for cell-wall synthesis of bacteria. The inhibitory concentration at 50% inhibition (IC(50)) of TCL against the Escherichia coli ENR is 150nM for wild type (WT), 380, 470 and 68,500nM for Ala, Ser and Val mutants, respectively. To understand this high TCL resistance in the G93V mutant, we obtained the crystal structures of mutated ENRs complexed with TCL and NAD(+). The X-ray structural analysis along with the ab initio calculations and molecular dynamics simulations explains the serious consequence in the G93V mutant complex. The major interactions around TCL due to the aromatic(cation)-aromatic and hydrogen bonding interactions are found to be conserved both in WT and mutant complexes. Thus, the overall structural change of protein is minimal except that a flexible α-helical turn around TCL is slightly pushed away due to the presence of the bulky valine group. However, TCL shows substantial edge-to-face aromatic (π)-interactions with both the flexible R192-F203 region and the residues in the close vicinity of G93. The weakening of some edge-to-face aromatic interactions around TCL in the G93V mutant results in serious resistance to TCL. This understanding is beneficial to design new generation of antibiotics which will effectively act on the mutant ENRs.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21094257     DOI: 10.1016/j.jsb.2010.11.008

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  5 in total

1.  Dynamics of Plasmodium falciparum enoyl-ACP reductase and implications on drug discovery.

Authors:  Steffen Lindert; J Andrew McCammon
Journal:  Protein Sci       Date:  2012-10-09       Impact factor: 6.725

2.  In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitors.

Authors:  Steffen Lindert; Lorillee Tallorin; Quynh G Nguyen; Michael D Burkart; J Andrew McCammon
Journal:  J Comput Aided Mol Des       Date:  2014-10-25       Impact factor: 3.686

3.  The impact of DNA adenine methyltransferase knockout on the development of triclosan resistance and antibiotic cross-resistance in Escherichia coli.

Authors:  Lewis Hughes; Wayne Roberts; Donna Johnson
Journal:  Access Microbiol       Date:  2020-11-18

4.  How Diverse Are the Protein-Bound Conformations of Small-Molecule Drugs and Cofactors?

Authors:  Nils-Ole Friedrich; Méliné Simsir; Johannes Kirchmair
Journal:  Front Chem       Date:  2018-03-27       Impact factor: 5.221

5.  Ligand- and Structure-Based Approaches of Escherichia coli FabI Inhibition by Triclosan Derivatives: From Chemical Similarity to Protein Dynamics Influence.

Authors:  Thales Kronenberger; Philipe de Oliveira Fernades; Isabella Drumond Franco; Antti Poso; Vinícius Gonçalves Maltarollo
Journal:  ChemMedChem       Date:  2019-11-07       Impact factor: 3.466

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.